Archer DX
We’re right where you need us
Invitae is a leading medical genetics company with world-class germline and somatic testing in a single, comprehensive platform. ArcherDX was acquired by Invitae in October 2020 and brings the somatic oncology offerings to the platform. ArcherDX's technologies are built on its proprietary Anchored Multiplex PCR (AMP™) chemistry that enables testing services for disease risk, therapy optimization and personalized cancer monitoring to advance precision approaches to cancer treatment.